(IN BRIEF) Novonesis and Novo Nordisk have formed a research partnership to study how the gut microbiome can support metabolic…
(IN BRIEF) Novo Nordisk has received a positive opinion from the European Medicines Agency’s CHMP recommending label expansion for Alhemo®…
(IN BRIEF) Effective 3 April 2025, Novo Nordisk will undergo key changes in its Executive Management. Camilla Sylvest, a long-time…
(IN BRIEF) Evotec and Novo Nordisk’s LAB eN² program, a translational drug discovery accelerator, has selected its first three academic…
(IN BRIEF) Novo Nordisk’s SOUL trial has shown that oral semaglutide reduces the risk of major adverse cardiovascular events (MACE)…
(IN BRIEF) Novo Nordisk’s Alhemo® (concizumab) has been recommended for approval by the European Medicines Agency's (EMA) Committee for Medicinal…
(IN BRIEF) Novo Nordisk has launched the Childhood Obesity Prevention Initiative, aimed at combating rising obesity rates among children in…
(IN BRIEF) EQT Life Sciences proudly announces Novo Nordisk's acquisition of Cardior Pharmaceuticals, valuing the biopharmaceutical company at up to…
(IN BRIEF) The Conference Forum announced the launch of the 8th annual Patients as Partners® Europe meeting, scheduled for May…
(IN BRIEF) Novo Nordisk is conducting a Capital Markets Day (CMD) to provide updates on its Strategic Aspirations 2025. The…
(IN BRIEF) Novo Nordisk has announced promising headline results from the kidney outcomes trial FLOW, which compared injectable semaglutide 1.0…
(IN BRIEF) Novo Nordisk A/S has announced the date for its Annual General Meeting, scheduled for Thursday, March 21, 2024,…
(IN BRIEF) Almirall S.A., a leading pharmaceutical company specializing in medical dermatology, has finalized an exclusive license agreement with Novo…
(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches…
(IN BRIEF) Novo Nordisk has unveiled plans to invest more than 42 billion Danish kroner starting in 2023 to expand…
(IN BRIEF) DHL Global Forwarding is experiencing a rising demand for sustainable transport solutions using fuels like Sustainable Aviation Fuels.…
(IN BRIEF) Novo Nordisk, a global healthcare company, has reported the headline findings from the SELECT cardiovascular outcomes trial. This…
(IN BRIEF) Novo Nordisk A/S is in exclusive negotiations to acquire a controlling stake in BIOCORP Production SA, a French…
(IN KÜRZE) Die LEGO Group und Novo Nordisk haben sich mit European Energy zusammengetan, um E-Methanol, eine kohlenstoffärmere Alternative zu…
(IN BRIEF) The LEGO Group and Novo Nordisk have partnered with European Energy to use e-methanol, a lower-carbon alternative to…